Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Glenmark Pharmaceuticals Limited
Press Release Apr 25 2022
Business
Apr 25 2022
4 min read

Press Release Apr 25 2022

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 25-Apr-2022 titled Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin + Pioglitazone Fixed-Dose Combination Drug for Type 2 Diabetes in India

View Attachment